ARTICLE | Financial News
Seventure leads Axial's $25M series B
March 1, 2019 8:08 PM UTC
Axial Biotherapeutics Inc. (Boston, Mass.) raised a $25 million series B led by Seventure Partners on the back of its Parkinson's disease and autism microbiome programs.
Existing investors Longwood Fund, Domain Associates and Heritage Medical Systems, plus undisclosed individual investors, also invested in the round...